Nektar Therapeutics
Innovative therapies for immune diseases
- B2B
About Nektar Therapeutics
Development and commercialization of innovative therapies targeting autoimmune and inflammatory diseases through scientific research and strategic pharmaceutical partnerships.
Key facts
- Industry
- Biotechnology
- Company size
- 251–1,000 employees
- Headquarters
- san francisco, california, United States
- Founded
- 1990
- Revenue
- $55.2MFY2025, publicly reported
- Website
- nektar.com
Nektar Therapeutics at a glance
Nektar Therapeutics is a B2B company in the Biotechnology industry, headquartered in san francisco, california, United States.
Nektar Therapeutics was founded in 1990.
Nektar Therapeutics has 251–1,000 employees.
Nektar Therapeutics's revenue is $55.2M (FY2025, publicly reported).
Selling to companies like Nektar Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies